Stock prices

Email this page to a friend

Want news about Stock prices and more e-mailed to you? Click here for free email alerts

Drug company investors to experience accelerating losses as pharmaceutical company stock prices continue to fall Mike Adams, the Health Ranger See article keywords and concepts

REPPED: The stock prices of drug companies have been hammered over the last six months thanks to a series of scandals regarding the safety of drugs that have long been approved by the FDA. It turns out that just because a drug is approved by the FDA doesn't at all mean it is safe. In fact, given the current evidence that is now surfacing, it appears that the FDA knowingly approves dangerous drugs and continues to support the use and marketing of those drugs to consumers, even while strong evidence exists that such drugs are quite literally killing people.

Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer Shannon Brownlee See book keywords and concepts

Direct-to-consumer advertising has been a spectacular success, boosting sales and stock prices beyond the dreams of the early drug marketers. Every dollar the pharmaceutical industry spends on consumer ads generates $4.20 in increased sales. That's a better return on investment than that of the fast food industry, which spends about as much on advertising. Nearly one in three adults has talked about a specific drug to their doctor in response to a drug advertisement; one in eight walked out with a prescription for the drug they asked for.

You Don't Have to be Afraid of Cancer Anymore Bill Sardi See book keywords and concepts

The increasing prices of cancer drugs appear to be engineered to elevate stock prices, not reward true breakthroughs. For example, the cancer drug Erbitux was heralded as a breakthrough and caused stock in ImClone System to rise dramatically, only to fall flat when the FDA rejected research studies on its effectiveness. (This is the drug that household television queen Martha Stewart sold off on an inside tip from Samuel D. Waksal, ImClone's chief executive.

New drug approvals, widely announced to the public to buoy stock prices and encourage public demand, may not be justified by the results of studies. For ethical reasons, new drugs should be compared with existing ones. An existing drug may be found to prolong survival times by six months and a new drug by nine months, which will likely be broadcast as a dramatic breakthrough increasing survival by 33-50%, depending how you compare the numbers (three months is half of six months, or a 50% increase; three months is a third of nine months, or a 33% increase).

It's all about money and stock prices, not cures. The pharmaceutical industry responds by saying there are newer types of monoclonal antibodies under development or in clinical testing. But the simple fact remains, cancer patients are guinea pigs and the FDA approves ineffective therapies for cancer. In contrast to the failures of monoclonal antibody drugs, a recent report says "/'/ is well established that mushroom-extracted compounds are commonly used as immune boosters" ... and that "over 30 mushroom species have shown anticancer action in animals.

For example, news sources heralded the combination of Avastin and Eloxatin. stock prices of the drug companies involved rose and analysts predicted billions of dollars in sales. But the patients were short changed. The overall improvement in survival went from 10.7 to 12.5 months using the combination of Avastin and Eloxatin rather than just Avastin. News reports claimed a 26% reduction in risk of death from colon cancer, but the translation into actual months of added life was often left out of the news reports or buried in lower paragraphs of the reports.

FDA refuses to pull dangerous diabetes drug Avandia, even knowing it will kill thousands Mike Adams, the Health Ranger See article keywords and concepts

On news of the FDA's vote, stock prices of GlaxoSmithKline LLC made the highest jump in two years. Business analysts noted the victory for Glaxo: "At 22-1, this was a clear endorsement of the product," said Peter Cartwright at Evolution Securities in London. "They've strengthened the label. Now Glaxo can get back on the road." And the FDA can get back to business killing people while pretending to be protecting them. The truth, friends, is that nobody needs Avandia. Type-2 diabetes can be easily reversed in just three weeks (50% success rate) by simple changes in diet and lifestyle.

Corporate greed, corruption, and the coming collapse of America as we know it Mike Adams, the Health Ranger See article keywords and concepts

Virtually everyone was caught up in the insane illusion that we would all get rich by selling each other pieces of paper with increasingly large numbers written on them (those are the stock prices, you see). Almost everybody was swept up by Groupthink, believing that the laws of economics had changed forever. CNBC became the cheerleader of unbridled greed, and brainwashed idiots at the American Enterprise Institute were publishing books predicting a Dow of 36,000 that would create infinite wealth requiring no effort or productive work.

Natural Health Solutions Mike Adams See book keywords and concepts

Meanwhile pharmaceutical stock prices continue to climb, and CEO compensation is more ludicrous every year. Downward spiral of disease management In 2005 prescribed for high cholesterol STATIN DRUGS Drug blocks cholesterol production Prescribed new drugs with new side effects (repeat) Drug blocks vitamin D production 2007: diagnosed with fictitious Osteoporosis Which inhibits calcium absorption The true dangers of drugs How dangerous are drugs, really?

The Long Emergency: Surviving the End of Oil, Climate Change, and Other Converging Catastrophes of the Twenty-First Century James Howard Kunstler See book keywords and concepts

As more people bought in, stock prices climbed still higher—a dangerous positive feedback loop. During the height of the mania, of course, many more stocks went up then went down. The middle class entered fearlessly into the realm of the "sure thing" reassured by the presence of the new and august Federal Reserve as a force that would stabilize the business cycle, and by such authorities as Harvard economics professor Irving Fisher, who declared the arrival of permanent prosperity a few weeks before the stock market crash of October 1929.

Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies Greg Critser See book keywords and concepts

If a lack of such ability ate into the company's production of a steady stream of blockbuster drugs, it could depress stock prices and create intense pressure by stockholders and board members. The issue was becoming an obstacle in the path of innovation and profits, at least as seen by top executives in all major pharmaceutical companies. As the industry bible, Pharmaceutical Executive, put it: "Nearly 80 percent of all clinical studies for new products fail to finish on time, and 20 percent of those are delayed six months or longer.

Natural Health Solutions Mike Adams See book keywords and concepts

The result? stock prices keep climbing, profits keep growing and CEOs get wealthier. You'd think this would be enough corruption for one industry, but Big Pharma is just getting started. Experiment shows medical doctors to be glorified drug dealers, easily manipulated by drug companies Researchers sent a group of people, who said they saw the drug Paxil in a TV advertisement, into doctors' offices.

With COX-2 decision, no longer any doubt about FDA corruption and U.S. drug racket Mike Adams, the Health Ranger See article keywords and concepts

This, in turn, would dramatically boost stock prices of drug companies and keep the drug profit machine churning away for years to come. (I wouldn't be surprised if the vast majority of the people on the FDA advisory panel, by the way, own stock in the very drug companies impacted by this decision.) It was brilliant theater, but bad medicine. And with this decision, whatever credibility the FDA thought it had remaining has now evaporated. The agency is suddenly the laughing stock of the world.

The FDA, Vioxx, and crimes against humanity Mike Adams, the Health Ranger See article keywords and concepts

Well, the answer is clear: Drug companies. The stock prices of Pfizer and Merck benefit; in fact, they shot up the moment this decision was made by the FDA advisory panel. The real benefit of these drugs is that they generate profits for the pharmaceutical industry, which the FDA seems sworn to protect. The pharmaceutical industry is the one reaping a benefit. What about the risks of the drugs? Well, it's very clear that the FDA takes no risk in allowing these drugs to be used. The pharmaceutical companies take no risk in allowing them to be used.

Big Pharma: Exposing the Global Healthcare Agenda Jacky Law See book keywords and concepts

Three-quarters of all deals do not pay back their cost of capital, and stock prices have fallen. However, I think the real question is not whether they delivered, but rather: what would have happened to these companies if they hadn't made the deal?'13 Size matters All the main pharma players are big. But some are bigger than others. The number one company, Pfizer, was worth $283.8 billion in April 2004- Based in New York, the firm had sales worth more than $40 billion in 2003, a 40% increase on 2002.

Natural Cures They Don't Want You to Know About Kevin Trudeau See book keywords and concepts

When the pharmaceutical companies get politicians to require drug use or have the government buy drugs from the pharmaceutical companies as exorbitant inflated prices, the pharmaceutical companies make billions of dollars in profits and their stock prices soar. What is the incentive for the politicians to do this? Well, I am now blowing the whistle on one of the greatest scandals in the history of American government. The members of Congress have passed a law which allows them to buy and sell stocks on, in effect, "insider information." Listen to this very carefully.

The Truth About the Drug Companies: How They Deceive Us and What to Do About It Marcia Angell, M.D. See book keywords and concepts

The immediate jump in pharmaceutical stock prices after the bill passed indicated that the industry and investors were well aware of the windfall. But at best, this legislation will be only a temporary boost for the industry. As costs rise, Congress will have to reconsider its industry-friendly decision to allow drug companies to set their own prices, no questions asked. More about that later. This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image.

For some companies, stock prices have plummeted. Nevertheless, the industry keeps promising a bright new day. It bases its reassurances on the notion that the mapping of the human genome and the accompanying burst in genetic research will yield a cornucopia of important new drugs. Left unsaid is the fact that big pharma is depending on government, universities, and small biotech companies for that innovation.

Profits, while still enormous, are starting to fall off, and stock prices for some of the largest companies are dropping. But instead of investing more in innovative drugs and moderating prices, drug companies are pouring money into marketing, legal maneuvers to extend patent rights, and government lobbying to prevent any form of price regulation. If prescription drugs were like ordinary consumer goods, all this might not matter very much. But drugs are different. People depend on them for their health and even their lives. In the words of Senator Debbie Stabenow (D-Mich.

As soon as the bill passed, stock prices of the big drug companies shot up, after a long period of decline. Investors knew good news when they saw it. And the news for senior citizens and the rest of the public? Not so good. The bill originally contemplated expenditures of $400 billion over ten years—or $40 billion a year.

Don't get caught in the housing bubble crash (part one) Mike Adams, the Health Ranger See article keywords and concepts

You don't have to be a genius to figure out that bubble was going to burst, and something very similar is happening today in the housing market. I'll explain all this later. The model of the dot-com bust First, let's get back to the dot-com market, because, in hindsight, it was easy to see that it was a bubble about to burst. Think about what you were doing in 1998, 1999 or 2000. You were probably invested in the stock market. You thought you were doing pretty well. You thought you were building up a huge retirement. Everybody was getting rich, at least on paper.

Natural Cures They Don't Want You to Know About Kevin Trudeau See book keywords and concepts

They know that once this vote is passed, certain pharmaceutical companies' stock prices will skyrocket. They then buy the stock knowing that the information about this windfall profit will be made public very soon. The congressmen have information that you and I do not have access to. They are given the right to make profits when you and I are denied that right. This should be criminal! In any other venue people would go to jail, but in Congress it is standard operating procedure. It's one of the perks of being a congressman or senator in Washington.

The Truth About the Drug Companies: How They Deceive Us and What to Do About It Marcia Angell, M.D. See book keywords and concepts

That creates a powerful incentive for executives to keep stock prices rising any way they can. Enron executives tried to do it illegally, but the incentive is the same in other investor-owned corporations that pay executives in stock options. Drug Pricing—What Does R&D Have to Do with It? Big pharma would like us to believe that prices of their top-selling drugs have to be high to cover their costs, including the costs of all the drugs that never make it to market. The implication is that drug companies are just eking out a living—something we know is a long way from the truth.

Natural Cures They Don't Want You to Know About Kevin Trudeau See book keywords and concepts

USA Today reports that biotech stock prices soar after good cancer drug news. This article points out the fact that publicly traded drug companies have only one goal: to increase profits, which means selling more drugs. The article never mentions if the drugs are effective at preventing or curing cancer, but only talks about how much money the companies will make by selling the drugs. • Hotels are increasingly using self-service check-in kiosks to reduce costs and increase profits.

The New Dictionary of Cultural Literacy: What Every American Needs to Know James Trefil, Joseph F. Kett, and E. D. Hirsch See book keywords and concepts

The street's name is often used in reference to the activities conducted on it: "Stock prices fell on Wall Street." warranty A guarantee of the quality of a product or service made by the seller to the buyer. watered stock Stock issued at an inflated price — that is, a price not warranted by the assets of the issuing company. welfare Government-provided support for those unable to support themselves.

The Dictionary of Cultural Literacy E. D. Hirsch See book keywords and concepts

The street's name is often used in reference to the activities conducted on it: "Stock prices fell on Wall Street." warranty A guarantee of the quality of a product or service made by the seller to the buyer. watered stock Stock issued at an inflated price — that is, a price not warranted by the assets of the issuing company. welfare Government-provided support for those unable to support themselves.

Crash of 1929, stock market An enormous decrease in stock prices on the stock exchanges of Wall Street in late Octobet 1929. This crash began the Great Depression. Crazy Horse A Sioux chief of the nineteenth century. Crazy Horse was one of the leaders of the Native American forces at the Battle of the Little Bighorn in 1876. Cross of Gold speech An address by the presidential candidate William Jennings Bryan to the national convention of the Democratic party in 1896.

Oxymorons: The Myth of a U.S. Health Care System J.D. Kleinke See book keywords and concepts

Earnings suffered, which pushed stock prices down throughout the industry. At the end of 1999, Congress passed a roughly $16.1 billion federal reimbursement relief package, restoring some of what had been cut in 1997.... Hospital chains are reaping increases in federal Medicare reimbursements ... helping them achieve and overshoot earnings targets" (Kirchheimer, 2000b, p. 81). This is consistent with Hav-ighurst's broader observation that "Medicare's most significant side effect was to make the health care sector an arena for profit-seeking activity more than ever before.

Food Politics Marion Nestle See book keywords and concepts

In an effort to shore up stock prices, RJR-Nabisco becomes a holding company for R. J. Reynolds (tobacco) and Nabisco Holdings (food); sells 19% of shares in Nabisco Holdings to the public. 1996 Philip Morris buys shares of Brazil's leading chocolate company, Industrias de Chocolate Lacta, S.A.; Kraft Foods acquires Taco Bell. 1999 RJR-Nabisco sells its international tobacco business; separates and renames its domestic tobacco (R. J. Reynolds Tobacco Holdings) and food businesses (Nabisco Group Holdings).

Bitter Pills: Inside the Hazardous World of Legal Drugs Stephen Fried See book keywords and concepts

The articles discussed how the introduction of the drug was expected to boost stock prices for the New Jersey-based pharmaceutical and toiletries behemoth Johnson & Johnson, a $14 billion firm best known for, besides its drugs, shampoos and baby products. The stories went on to explain how J&J's profits in the first quarter of 1991, when Floxin hit the American market, had jumped 13 percent. In the third quarter of 1992, which ended just weeks before my wife was Floxed, earnings were up another 17 percent.

page 1 of 2 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalNews.com/np/index.html

This unique compilation of research is copyright (c) 2008 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of this NaturalNews Naturalpedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.